Intellia Therapeutics Inc.Equity-NMS: NTLA
Equity-NMS: NTLA
$25.89
-0.33
(20 May)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$25.89
Open
$25.89
Today’s high
$26.41
Today’s low
$25.72
52W low
$19.37
52W high
$47.48
1Y
-38.22%
5Y
11.57%
PE
-5.21
EPS (TTM)
-5.35
Shares O/S
96.48M
Market cap
2.5B
Insights
NTLA price is above its 200 day moving average
NTLA PE is in the top end of its range over the past 2 years
NTLA is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Intellia Therapeutics Inc.

Intellia Therapeutics, Inc. is a clinical-stage genome editing company, which is focused on developing curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) technology. CRISPR/Cas9 is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid.

It is focused on leveraging its modular platform to advance in vivo and ex vivo therapies for diseases with high unmet need. Its lead in vivo candidate, NTLA-2001, is for the treatment of transthyretin (ATTR) amyloidosis, as well as NTLA-2002 for the treatment of hereditary angioedema (HAE) are the first CRISPR/Cas9-based therapy candidates to be administered systemically, via intravenous (IV) infusion, for precision editing of a gene in a target tissue in humans. It is also developing ex vivo applications to address immuno-oncology and autoimmune diseases. .


FAQs

Can I buy Intellia Therapeutics Inc. shares in India?
How to buy Intellia Therapeutics Inc. shares in India?
What is the share price of Intellia Therapeutics Inc.?
What is the Market Capitalization of Intellia Therapeutics Inc.?
What is the PE ratio of Intellia Therapeutics Inc.?
Is Intellia Therapeutics Inc. a good stock to buy?
In which sector / industry does Intellia Therapeutics Inc. operate?